Calpain inhibitors reduce retinal hypoxia in ischemic retinopathy by improving neovascular architecture and functional perfusion
- 1 April 2011
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1812 (4) , 549-557
Abstract
No abstract availableKeywords
Funding Information
- V. Kann Rasmussen Foundation (CA129339, NS064498, EY017017, EY017017-S)
- NIH
- The Roche Foundation for Anemia Research
- Research to Prevent Blindness Senior Investigator Award
This publication has 42 references indexed in Scilit:
- Endogenous VEGF Is Required for Visual Function: Evidence for a Survival Role on Müller Cells and PhotoreceptorsPLOS ONE, 2008
- The Role of Calcium-Activated Protease Calpain in Experimental Retinal PathologySurvey of Ophthalmology, 2008
- Retinopathy of prematurityAngiogenesis, 2007
- Calpain-Specific Proteolysis in Primate Retina: Contribution of Calpains in Cell DeathInvestigative Ophthalmology & Visual Science, 2006
- Synthesis and biological evaluation of chromone carboxamides as calpain inhibitorsBioorganic & Medicinal Chemistry Letters, 2005
- On the Sequential Determinants of Calpain CleavageJournal of Biological Chemistry, 2004
- Retinal OxygenArchives of Ophthalmology (1950), 2003
- Disruption of the Murine Calpain Small Subunit Gene, Capn4 : Calpain Is Essential for Embryonic Development but Not for Cell Growth and DivisionMolecular and Cellular Biology, 2000
- Calpain cleavage of integrin β cytoplasmic domainsFEBS Letters, 1999
- Microscopic Visualization of the Retina by Angiography with High-Molecular-Weight Fluorescein-Labeled Dextrans in the MouseMicrovascular Research, 1993